Notably, levels of KPNA2 protein in the pleural effusions obtained from patients with NSCLC have been found to be substantially higher compared with those from individuals without lung cancer, and knockdown of KPNA2 in lung cancer cells inhibits cell migration and reduces their viability [30]. This evidence concerns the gene KPNA2 and Pleural effusion.